Fall | Underraduate | Units: 3-0-9 | Prereq: None
Some of the most exciting and impactful engineering work involves the translation of new healthcare technology from the benchtop to the bedside. There are countless great discoveries and technologies being developed at MIT many of them being launched into new companies. However, translating new technologies into practice can often be challenging and fraught with failure. This course will provide an in-depth view of translating technologies with input from national leaders in the translational engineering space.
This will be a seminar and project-based course that will provide hands-on experience into the pre-clinical, regulatory, manufacturing, clinical trial, venture capital and legal needs for the successful translation of biomedical developments. These seminars are given by CEOs of biotechnology companies, leaders in the FDA, patent lawyers, MIT and local entrepreneurs, professors, journal editors, and foundations. To supplement the seminars, students will work on a course project that will involve the creation of a prototypic new company focused upon the development and translation of a medical device for the treatment of common pancreatic condition.
Overall, this course will provide an opportunity to experience the start-up of a new company and the steps toward successfully launching a new technology with instruction from national leaders.
Spring 2021 Update: Fully Remote Class.